SRZN Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 6.21%, SMA50 16.18%, SMA200 81.53%). The stock’s 14-day RSI is 59.36 (neutral), while the ATR of 2.12 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -7.9% below its high and over 336.44% above its low. Average 10-day trading volume of 108.28 thousand shares is slightly above the 3-month average of 95.52 thousand, indicating heightened recent market interest.

Surrozen, Inc. generated EPS of -$21.83 over the past year. Five-year average earnings growth is 14.8%. Wall Street analysts project EPS growth of 44.03% annually over the next five years. The latest quarter delivered EPS of -$7.59. The next quarter is forecast at -$1.29. Next year's EPS is expected at $44.44. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $44.00 to $36.00. The high target offers 51.93% upside. The low target suggests 24.31% downside. The mean target is $40.00. This offers 38.12% upside. Surrozen, Inc. earnings surprise history is a mixed track record. The quarter that ended March 23, 2026, missed forecasts by 438.3%. The prior quarter beat by 626.96%. Over the last six quarters, Apple has recorded several small beats. These include -84.12% in November 06, 2024.

Surrozen, Inc. has 8.57 million shares outstanding. The public float is 4.80 million shares, elevated short interest at 1.17% of float. This equals 88.40 thousand shares. The short ratio is 5.85 days. Institutional investors hold 97.45% of the float. Insiders own 3.09%. COLUMN GROUP III GP, LP holds 900.29 thousand shares, Kutzkey Tim has 900.29 thousand shares and TCG Crossover GP II, LLC has 736.55 thousand shares. Over the past six months, insider transactions show net buying. They sold 10.83 thousand shares across 5 transactions.

Surrozen, Inc. (NASDAQ:SRZN) closed at $28.96 USD, losing -$1.79 (-5.82%) from the previous close of $30.75. The stock is currently mid-range between its 52-week high and low $5.90 and $35.00. With a market capitalization of about $216.55 million, Surrozen, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.59). Key stats such as the average daily volume over the past year has been around 101.73 thousand shares, volume is running light vs its 52-week average. Headquartered in South San Francisco, CA, Surrozen, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Craig C. Parker, the company employs approximately 40 people and listed since January 11, 2021. Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration.

Surrozen, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.82. This means the shares are trading above this model’s fair value.

Surrozen, Inc. trades at a P/E ratio of -1.47, slightly below the S&P 500 average, with a price-to-sales ratio of 28.89 and a price-to-book ratio of -1.14 indicating negative book value, which may reflect financial stress. The P/FCF stands at -6.43, also below market averages.

Surrozen, Inc. (NASDAQ:SRZN) shares are down -20.44% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Surrozen, Inc. trading at a premium to the broader market with a P/E of -1.47. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $29.09, suggesting 0.45% upside. Our AI forecast model points to short-term strength (11.08% over two weeks), a medium-term rise (28.07% over three months), and a longer-term gain (24.31% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Surrozen, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.08%, with price expected at $32.17 by May 22, 2026, within a range of $30.44 to $33.76 3-Month Outlook: Projected rise of 28.07%, reaching $37.09 by August 05, 2026, with a range of $35.63 to $38.65. 1-Year Outlook: Projected gain of 24.31%, with price at $36.00 by May 07, 2027, within a range of $34.24 to $37.88.